21 participants
Avelumab in Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY]
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-09-24
- Start Date:
- 2018-01-16
- Completion:
- 2022-01-30
Conditions
- Lymphoma, Extranodal NK-T-Cell
Interventions
- DRUG
No Results Yet